106 related articles for article (PubMed ID: 23808708)
21. Drug repurposing for drug development in stroke.
Fagan SC
Pharmacotherapy; 2010 Jul; 30(7 Pt 2):51S-4S. PubMed ID: 20575622
[TBL] [Abstract][Full Text] [Related]
22. Discovering new treatments for Alzheimer's disease by repurposing approved medications.
Appleby BS; Cummings JL
Curr Top Med Chem; 2013; 13(18):2306-27. PubMed ID: 24059463
[TBL] [Abstract][Full Text] [Related]
23. Alzheimer's disease: cognitive and behavioral pharmacotherapy.
Cummings JL; Mendez MF
Conn Med; 1997 Sep; 61(9):543-52. PubMed ID: 9334509
[TBL] [Abstract][Full Text] [Related]
24. Combination drug therapy for Alzheimer's disease: what is evidence-based, and what is not?
Xiong G; Doraiswamy PM
Geriatrics; 2005 Jun; 60(6):22-6. PubMed ID: 15948662
[TBL] [Abstract][Full Text] [Related]
25. Potentially inappropriate prescribing (IP) for elderly medical inpatients in Taiwan: a hospital-based study.
Liu CL; Peng LN; Chen YT; Lin MH; Liu LK; Chen LK
Arch Gerontol Geriatr; 2012; 55(1):148-51. PubMed ID: 21820189
[TBL] [Abstract][Full Text] [Related]
26. Insights into the Drug Repositioning Applied to the Alzheimer's Disease Treatment and Future Perspectives.
de Castro AA; da Cunha EFF; Pereira AF; Soares FV; Leal DHS; Kuca K; Ramalho TC
Curr Alzheimer Res; 2018; 15(12):1161-1178. PubMed ID: 30101709
[TBL] [Abstract][Full Text] [Related]
27. Comparison of combination therapies, including the angiotensin receptor blocker olmesartan and either a calcium channel blocker or a thiazide diuretic, in elderly patients with hypertension.
Kato J; Yokota N; Tamaki N; Kariya S; Kita T; Ayabe T; Eto T; Kitamura K
Hypertens Res; 2011 Mar; 34(3):331-5. PubMed ID: 21124326
[TBL] [Abstract][Full Text] [Related]
28. [Pharmacotherapeutical perspectives in Alzheimer's disease].
Martínez-Lage JM
Rev Neurol; 1997 Jul; 25 Suppl 1():S63-9. PubMed ID: 9280669
[No Abstract] [Full Text] [Related]
29. Current therapies and new strategies for the management of Alzheimer's disease.
Aderinwale OG; Ernst HW; Mousa SA
Am J Alzheimers Dis Other Demen; 2010 Aug; 25(5):414-24. PubMed ID: 20601643
[TBL] [Abstract][Full Text] [Related]
30. [The effects of cholinergic preparations in Alzheimer's disease].
Bradley RJ; Edge MT; Freeman AM
Farmakol Toksikol; 1991; 54(3):4-10. PubMed ID: 1915820
[No Abstract] [Full Text] [Related]
31. [Modern approaches to the treatment of primary arterial hypertension].
Bokarev IN; Matvienko EV
Klin Med (Mosk); 2013; 91(3):4-8. PubMed ID: 23789444
[TBL] [Abstract][Full Text] [Related]
32. [Treatment of Alzheimer's disease utilising the best available evidence-based medicine -- utopia?].
Stoppe G; Pirk O; Haupt M
Gesundheitswesen; 2005 Jan; 67(1):20-6. PubMed ID: 15672302
[TBL] [Abstract][Full Text] [Related]
33. Assessment and management of left ventricular hypertrophy in Type 2 diabetes patients with high blood pressure.
Derosa G; Maffioli P
Expert Rev Cardiovasc Ther; 2013 Jun; 11(6):719-28. PubMed ID: 23750681
[TBL] [Abstract][Full Text] [Related]
34. DOTA: Deep Learning Optimal Transport Approach to Advance Drug Repositioning for Alzheimer's Disease.
Chyr J; Gong H; Zhou X
Biomolecules; 2022 Jan; 12(2):. PubMed ID: 35204697
[TBL] [Abstract][Full Text] [Related]
35. Drug repositioning approaches for the discovery of new therapeutics for Alzheimer's disease.
Kim TW
Neurotherapeutics; 2015 Jan; 12(1):132-42. PubMed ID: 25549849
[TBL] [Abstract][Full Text] [Related]
36. Office management of hypertension in older persons.
Aronow WS
Am J Med; 2011 Jun; 124(6):498-500. PubMed ID: 21605724
[TBL] [Abstract][Full Text] [Related]
37. The brain RAS and Alzheimer's disease.
Wright JW; Harding JW
Exp Neurol; 2010 Jun; 223(2):326-33. PubMed ID: 19782074
[TBL] [Abstract][Full Text] [Related]
38. Neuroprotective therapeutics for Alzheimer's disease: progress and prospects.
Palmer AM
Trends Pharmacol Sci; 2011 Mar; 32(3):141-7. PubMed ID: 21256602
[TBL] [Abstract][Full Text] [Related]
39. Roles of β-adrenergic receptors in Alzheimer's disease: implications for novel therapeutics.
Yu JT; Wang ND; Ma T; Jiang H; Guan J; Tan L
Brain Res Bull; 2011 Feb; 84(2):111-7. PubMed ID: 21129453
[TBL] [Abstract][Full Text] [Related]
40. Effects of exercise therapy alone and in combination with a calcium channel blocker or an angiotensin receptor blocker in hypertensive patients.
Ohta M; Tajiri Y; Yamato H; Ikeda M
Clin Exp Hypertens; 2012; 34(7):523-9. PubMed ID: 22559159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
